Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype Antonio Marchesoni Commentary Open access 01 June 2018 Pages: 311 - 316
Chikungunya Infection: A Re-emerging Epidemic Binoy J. PaulShajit Sadanand Review Open access 25 July 2018 Pages: 317 - 326
Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK Sara GaleJessica C. WilsonKhaled Sarsour Original Research Open access 11 May 2018 Pages: 327 - 340
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses Vibeke StrandArthur KavanaughJosef S. Smolen Original Research Open access 14 May 2018 Pages: 341 - 353
Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population David M. KernLawrence ChangAndre B. Araujo Original Research Open access 30 May 2018 Pages: 355 - 369
Patients with Rheumatic Diseases do not have an Increased Risk of MRSA Carrier Status Judith KrämerKonstantinos TriantafylliasAndreas Schwarting Original Research Open access 02 June 2018 Pages: 371 - 381
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population Stephen HallPeter NashKrishan Thirunavukkarasu Original Research Open access 11 June 2018 Pages: 383 - 401
Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials Steven RamaelBenjamin Van HoorickGirish Jayadeva Original Research Open access 29 June 2018 Pages: 403 - 421
Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional Study Kurt de VlamJoseph F. MerolaWolf-Henning Boehncke Original Research Open access 06 July 2018 Pages: 423 - 436
The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study Khalid ShirazyNajia Hajjaj-HassouniBonnie Vlahos Original Research Open access 02 August 2018 Pages: 437 - 445
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study Alan J. KivitzUlf WagnerBrian Porter Original Research Open access 18 August 2018 Pages: 447 - 462
Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database Jessica A. WalshXue SongYujin Park Original Research Open access 18 August 2018 Pages: 463 - 474
Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in Dogs Neil BodickToni WilliamsonRuth Lightfoot-Dunn Original Research Open access 10 September 2018 Pages: 475 - 498
Clinical and Immunological Features of Anti-centromere Antibody-Positive Primary Sjögren’s Syndrome Masako TsukamotoKatsuya SuzukiTsutomu Takeuchi Original Research Open access 25 September 2018 Pages: 499 - 505
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis Leslie R. HarroldGeorge W. ReedJoel M. Kremer Original Research Open access 06 October 2018 Pages: 507 - 523
Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids Ronald van VollenhovenCameron HeltDavid Muram Original Research Open access 24 October 2018 Pages: 525 - 536
Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry Philip J. MeaseDésirée van der HeijdeJeffrey D. Greenberg Original Research Open access 23 October 2018 Pages: 537 - 550
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study Boulos HaraouiShahin JamalMajed Khraishi Original Research Open access 28 October 2018 Pages: 551 - 565
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies Peter NashLaura C. CoatesWilliam C. Ports Original Research Open access 09 November 2018 Pages: 567 - 582
Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases Allan H. MortonTony HoseyBrian LaMoreaux Case Series Open access 03 May 2018 Pages: 583 - 594
Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison Peter NashIain B. McInnesSteffen M. Jugl Correction Open access 01 June 2018 Pages: 595 - 595